Multiple-dose pharmacokinetics, pharmacodynamics, and safety — 2008 Laboratory Study - | BudProfiles
NegativeLaboratory Study -2008
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers